Dry recombinant human alpha 1-antitrypsin formulation

Details for Australian Patent Application No. 2004288854 (hide)

International Classifications

Event Publications

29 June 2006 PCT application entered the National Phase

PCT publication WO2005/047323 Priority application(s): WO2005/047323

7 May 2009 Assignment before Grant

Arriva-Prometic Inc. The application has been assigned to Arriva-Pharmaceuticals, Inc.

1 October 2009 Application Accepted

Published as AU-B-2004288854

4 March 2010 Standard Patent Sealed

7 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.